insights_auto
Why is PRME down 5.93%?
Dive Deeperchevron_right
PRME:NASDAQ
Prime Medicine, Inc
$4.44
arrow_downward
-5.93%(-0.28) 1D
$4.44
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRME...
Open
$4.86
High
$4.86
Low
$4.36
Mkt. cap
805.31M
Avg. vol.
5.50M
Volume
4.12M
52-wk high
$5.91
52-wk low
$2.67
EPS
-$1.09
Beta
2.37
Shares outstanding
181.38M
No. of employees
146
Open
$4.86
High
$4.86
Low
$4.36
Mkt. cap
805.31M
Avg. vol.
5.50M
Volume
4.12M
52-wk high
$5.91
52-wk low
$2.67
EPS
-$1.09
Beta
2.37
Shares outstanding
181.38M
No. of employees
146
News stories
From web sources and news partners
investingLive
·
5 minutes ago
Nasdaq’s worst month since March 2025 puts returns on AI spending in focus, says BlackRock
Foreign Policy Journal
·
51 minutes ago
Applied Digital's (NASDAQ: APLD) Interest Bill Surpasses Rent Revenue As 800 MW Financing Gap Rattles AI Infrastructure Sector
investingLive
·
1 hour ago
JPMorgan’s four midterm scenarios: S&P 500 seen moving between -0.25% and +1.25%
Bloomberg.com
·
1 hour ago
Nasdaq Slide Clouds Asian Open, Oil Falls on Iran: Markets Wrap
Profile
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts. Wikipedia
About Prime Medicine, Inc